Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Bio-Technologies (ABT) was a specialty medical company focused on the development and commercialization of dermatological products, specifically for scar management. The company is best known for its patented silicone gel technology, Kelo-cote, which is used to treat and prevent hypertrophic and keloid scars resulting from burns, trauma, or surgery. ABT's products became a global standard in scar care before the company was acquired to expand the dermatology portfolios of larger pharmaceutical entities. Its legacy continues through the widespread clinical use of its silicone-based topical treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Bio-Techniques.